Investing.com - Goodrx (NASDAQ: GDRX) reported fourth quarter EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $195.92M versus the consensus estimate of $194.32M.
Goodrx's stock price closed at $6.47. It is up 1.57% in the last 3 months and up 17.64% in the last 12 months.
Goodrx saw 4 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Goodrx's stock price’s past reactions to earnings here.
According to InvestingPro, Goodrx's Financial Health score is "great performance".
Check out Goodrx's recent earnings performance, and Goodrx's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar